Novo Nordisk (NVO) Twitter Mentions Statistics 2025

412 2.2%

1W 54.3% 1M 67.5% 3M 42.1%

Est. daily mentions on Twitter.

Similar companies

Company		Twitter Mentions
	Johnson & Johnson JNJ	195 58.5%
	Eli Lilly and Company LLY	129 17.8%
	Pfizer PFE	233 38.7%
	Astrazeneca AZN	41 95.2%
	AbbVie ABBV	133 42.7%

Month over Month

Est. daily mentions on Twitter.

Sep 2025	355	45.8%
Aug 2025	655	55.3%
Jul 2025	421	5.8%
Jun 2025	399	75.6%
May 2025	227

How often is NVO mentioned on X?

The cashtag $NVO was mentioned an estimated 412 times in X posts yesterday.

Analyzing Twitter Mentions, how is Novo Nordisk performing compared to its industry peers?

Novo Nordisk overperforms all of its industry peers when it comes to Twitter Mentions, having more Twitter Mentions than any of its peers.

Why is it important to track Twitter mentions for Novo Nordisk?

By monitoring Twitter mentions for Novo Nordisk, investors gain real-time insights into public sentiment towards the company, its products, and its industry. Positive mentions may indicate growing interest, customer satisfaction, or emerging trends, while negative mentions can alert investors to potential issues, controversies, or market challenges. By tracking these mentions over time, investors can identify patterns, spot emerging trends, and make informed decisions based on the evolving sentiment and public perception of Novo Nordisk, ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.